Novasep Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1,250
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • (Announced)
  • Financing Rounds
  • 10
  • Investments
  • 4

Novasep General Information

Description

Provider of contract manufacturing services developing complex small molecules predominantly for pharma and biotech customers. The company provides process development, process engineering, contract manufacturing of chemicals and intermediates for the fine chemical and agro-chemical industries and other related services.

Contact Information

Website
www.novasep.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
BPO/Outsource Services
Other Industries
Specialty Chemicals
Parent Company
Primary Office
  • 39, rue St Jean de Dieu
  • 69007 Lyon
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novasep Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novasep‘s full profile, request access.

Request a free trial

Novasep Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of contract manufacturing services developing complex small molecules predominantly for pharma and biotech cust
BPO/Outsource Services
Lyon, France
1,250 As of 2022
00000
000000000000

00 00000

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
000000000 000000000
Houston, TX
00 As of 0000
0000
000000&0 0000

000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000 000000000
Morrisville, PA
000 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novasep Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GC International (Specialty Chemicals) Formerly VC-backed Houston, TX 00 0000 000000&0 0000
000000 Formerly PE-Backed Morrisville, PA 000 00000 000000&0 00000
0000000 Private Equity-Backed Beuvry-la-Forêt, France 000 0000 000000000000 0000
00000 000000000000 Corporate Backed or Acquired Goole, United Kingdom 0000 00000 000000000 00000
0000 00000 Corporate Backed or Acquired United Kingdom 000 000000&0
You’re viewing 5 of 8 competitors. Get the full list »

Novasep Patents

Novasep Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140336400-A1 Chromatographic process for the production of highly purified polyunsaturated fatty acids Granted 07-May-2013 0000000000 0
US-9428711-B2 Chromatographic process for the production of highly purified polyunsaturated fatty acids Active 07-May-2013 0000000000 0
GB-2528618-B Chromatographic process for the production of highly purified polyunsaturated fatty acids Active 07-May-2013 00000000
CA-2911273-C Chromatographic process for the production of highly purified polyunsaturated fatty acids Active 07-May-2013 0000000000
GB-2528618-A Chromatographic process for the production of highly purified polyunsaturated fatty acids Granted 07-May-2013 C11C1/08
To view Novasep’s complete patent history, request access »

Novasep Executive Team (9)

Name Title Board Seat Contact Info
Jean Bléhaut President, Biopharma Solutions Business Unit
Pierre-Louis Mikus Chief Legal Officer
Michel Spagnol Ph.D Chairman of the Supervisory Board & Chief Executive Officer
Olivier Cheron Chief Financial Officer
You’re viewing 4 of 9 executive team members. Get the full list »

Novasep Board Members (2)

Name Representing Role Since
000000 0000000 00.0 Novasep Chairman of the Supervisory Board & Chief Executive Officer 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Novasep Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novasep Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novasep‘s full profile, request access.

Request a free trial

Novasep Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 02-Jul-2009 0000000000 Biotechnology 00000 000
0000000000 00 18-Sep-2007 0000000000 Biotechnology 00000 000
0000000 00000 01-Dec-2006 0000000000 Biotechnology
Rohner 01-Jan-2004 Merger/Acquisition Multi-line Chemicals
To view Novasep’s complete investments and acquisitions history, request access »

Novasep Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000 02-Jul-2009 0000000000 Completed
  • 3 buyers
0000000000 0000000 18-Sep-2007 0000000000 Completed
  • 3 buyers
0000000 0000000000 01-Dec-2006 000000000000000000 Completed
  • 0000000
Rohner 01-Jan-2004 Merger/Acquisition Completed
To view Novasep’s complete exits history, request access »